New dialysis device for Wilson's disease tested but trial stopped early
NCT ID NCT05917327
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial tested a special dialysis device (MEX-CD1) designed to remove extra copper from the blood of people with Wilson's disease, a genetic condition that causes copper buildup. The study planned to give 5 to 10 treatments over consecutive days and check if the device worked safely. However, the trial was stopped early after enrolling only one person, so results are very limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOLENTICULAR DEGENERATION; WILSON are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Clinic Barcelona, Liver ICU
Barcelona, Catalonia, 08036, Spain
-
Hospital Universitario Vall d'Hebron, Unitat de Trasplantament Hepàtic Pediàtric
Barcelona, Catalonia, 08035, Spain
-
Hôpital Croix Rousse, Service d'hépatologie et gastroentérologie
Lyon, Auvergne-Rhône-Alpes, 69317, France
-
Hôpital Femme Mère Enfant, Service des urgences et la réanimation pédiatriques
Bron, Auvergne-Rhône-Alpes, 69500, France